Department of Biomedical Engineering, Tufts University, Medford, Massachusetts, USA.
Tissue Eng Part C Methods. 2010 Dec;16(6):1565-73. doi: 10.1089/ten.TEC.2010.0241. Epub 2010 Jul 13.
Large-scale tissue engineering is limited by nutrient perfusion and mass transport limitations, especially oxygen diffusion, which restrict construct development to smaller than clinically relevant dimensions and limit the ability for in vivo integration. The goal of this work was to develop a modular approach to tissue engineering, where scaffold and tissue size, transport issues, and surgical implantation in vivo are considered from the outset. Human mesenchymal stem cells (hMSCs) were used as the model cell type, as their differentiation has been studied for several different cell lineages and often with conflicting results. Changes in the expression profiles of hMSCs differentiated under varied oxygen tensions are presented, demonstrating tissue-specific oxygen requirements for both adipogenic (20% O₂) and chondrogenic (5% O₂) differentiation. Oxygen and nutrient transport were enhanced by developing a bioreactor system for perfusing hMSC-seeded collagen gels using porous silk tubes, resulting in enhanced oxygen transport and cell viability within the gels. These systems are simple to use and scaled for versatility, to allow for the systematic study of relationships between cell content, oxygen, and cell function. The data may be combined with oxygen transport modeling to derive minimally sized modular units for construction of clinically relevant tissue-engineered constructs, a generic strategy that may be employed for vascularized target tissues.
大规模组织工程受到营养灌注和质量传输限制的限制,特别是氧气扩散,这限制了构建体的发展小于临床相关的尺寸,并限制了体内整合的能力。这项工作的目标是开发一种组织工程的模块化方法,从一开始就考虑支架和组织的大小、传输问题以及体内的手术植入。人骨髓间充质干细胞(hMSC)被用作模型细胞类型,因为它们的分化已经在几种不同的细胞谱系中进行了研究,而且通常结果相互矛盾。呈现了在不同氧张力下分化的 hMSC 的表达谱变化,证明了脂肪生成(20% O₂)和软骨生成(5% O₂)分化对组织特异性氧气的需求。通过开发一种使用多孔丝管对 hMSC 接种胶原凝胶进行灌注的生物反应器系统,增强了氧气和营养物质的传输,从而提高了凝胶内的氧气传输和细胞活力。这些系统易于使用且可扩展以实现多功能性,从而可以系统地研究细胞含量、氧气和细胞功能之间的关系。可以将数据与氧气传输建模相结合,以获得构建临床相关组织工程构建体的最小尺寸模块化单元,这是一种可用于血管化靶组织的通用策略。